SAGE for the Early Detection of Cognitive Impairment at Primary Care Provider Visits

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

April 6, 2020

Study Completion Date

July 7, 2020

Conditions
Cognitive Impairment
Interventions
OTHER

Self-Administered Gerocognitive Examination (SAGE) or Electronic Self-Administered Gerocognitive Examination (eSAGE)

The Self-Administered Gerocognitive Examination (SAGE) is a reliable and valid assessment that is used to detect MCI and early dementia. It is a pen and paper assessment that has 4 interchangeable versions. The digital version of SAGE (eSAGE; commercially known as BrainTest®) is made for tablet use, consists of the identical test questions as SAGE, and is strongly associated with the validated SAGE.

OTHER

Informant Conversation

If possible, the provider will have a conversation with an individual who knows the patient will to ascertain if a significant change (based on primary care provider opinion) occurred in the patient's cognitive skills over the previous year.

Trial Locations (1)

43221

The Ohio State University, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

NCT04063371 - SAGE for the Early Detection of Cognitive Impairment at Primary Care Provider Visits | Biotech Hunter | Biotech Hunter